Monroe Capital Corporation Schedules Third Quarter 2025 Earnings Release GlobeNewswire October 30, 2025 CHICAGO, Oct. 30, 2025 (GLOBE NEWSWIRE) — Monroe Capital Corporation (the “Company”) (NASDAQ: MRCC) announced today that it will report its third quarter ended September 30, 2025 financial results on Wednesday, November 5, 2025, after the close of the financial markets. About […]
(NASDAQ:WESFX), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In The Wildermuth Fund To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in The Wildermuth Fund between November 1, 2020 and June 29, 2023 and would like to discuss your legal
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Wildermuth Fund GlobeNewswire October 30, 2025 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In The Wildermuth Fund To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in
Omnicom Group Inc. (“Omnicom”) (NYSE: OMC) and The Interpublic Group of Companies, Inc. (“IPG”) (NYSE: IPG) today announced that, in connection with the closing of the merger between Omnicom and IPG expected by the end of November, Omnicom has extended the expiration date of its previously announced exchange offers and consent solicitations for IPG's outstanding
NEW YORK, NY / ACCESS Newswire / October 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ:ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK, NY / ACCESS Newswire / October 30, 2025 / If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ:MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=174791&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / October 30, 2025 / If you suffered a loss on your James Hardie Industries plc. (NYSE:JHX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/james-hardie-industries-plc-lawsuit-submission-form?prid=174789&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com
(NYSE:BAX), NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. (NYSE: BAX). Shareholders who purchased shares of BAX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to
Baxter International, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights – BAX GlobeNewswire October 30, 2025 NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. (NYSE: BAX). Shareholders who purchased
Robert Half Inc. (NYSE: RHI) today announced that its board of directorshas approved a quarterly cash dividend of $0.59 per share on the company's common stock. The cash dividend is payable on December 15, 2025, to all shareholders of record at the close of business on November 25, 2025. https://mma.prnewswire.com/media/2188927/Robert_Half_v2_Logo.jpg About Robert Half Robert Half